Related references
Note: Only part of the references are listed.First-Line Therapy for Chronic Graft-versus-Host Disease that Includes Low-Dose Methotrexate Is Associated with a High Response Rate
Yu Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation
Xiao-Jun Huang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
Marco Mielcarek et al.
BLOOD (2009)
Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children
J. Inagaki et al.
BONE MARROW TRANSPLANTATION (2008)
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
X. -J. Huang et al.
BONE MARROW TRANSPLANTATION (2006)
Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
XJ Huang et al.
BONE MARROW TRANSPLANTATION (2005)
The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules
A Johnston et al.
CLINICAL IMMUNOLOGY (2005)
Share Paper
